Literature DB >> 8012695

A comparison of A2 adenosine receptor-induced cyclic AMP generation in cerebral cortex and relaxation of pre-contracted aorta.

S P Alexander1, A Losinski, D A Kendall, S J Hill.   

Abstract

1. A comparative study was carried out between the adenosine receptor mediating a stimulation of cyclic AMP formation in guinea-pig cerebral cortical slices with the adenosine receptor mediating relaxation of phenylephrine precontracted guinea-pig aortic rings. 2. [3H]-cyclic AMP accumulation in [3H]-adenine-prelabelled guinea-pig cerebral cortical slices was stimulated by adenosine and its analogues with the following EC50 values (microM): 5'-N-ethylcarboxamidoadenosine (3.1 +/- 0.3) > 2-chloroadenosine (10 +/- 2) > adenosine (109 +/- 15). 3. 2-Chloroadenosine and adenosine elicited maximal responses for [3H]-cyclic AMP accumulation that were 100 +/- 7 and 71 +/- 6% of the maximal response to 5'-N-ethylcarboxamidoadenosine, respectively. CGS 21680 (100 microM) and DPMA (100 microM) elicited -2 +/- 2 and 12 +/- 3% of the response to 100 microM 5'-N-ethylcarboxamidoadenosine. 4. Estimation of antagonist potencies at the A2 adenosine receptor of cerebral cortex showed a rank order of potency (K1, nM): xanthine amino congener (35 +/- 3) > 8-cyclopentyl-1,3-dipropylxanthine (130 +/- 22) > PD 115,199 (407 +/- 82) > 3,7-dimethyl-1-propargylxanthine (13 +/- 2 microM). 5. Adenosine analogues produced long-lasting relaxation of phenylephrine-precontracted aortic rings with the following rank order of potency (EC50 values, microM): 5'-N-ethylcarboxamidoadenosine (0.68 +/- 0.06) > 2-chloroadenosine (4.3 +/- 0.6) > adenosine (104 +/- 13). Maximal relaxations elicited by these agents were 71 +/- 3, 98 +/- 1, and 100 +/- 1%, respectively. CGS 21680 and DPMA at 100 microM elicited smaller relaxations of the precontracted tissues (12 +/- 2 and 43 +/- 15%, respectively). 6. Antagonism by xanthine derivatives of the 5'-N-ethylcarboxamidoadenosine-induced relaxation of aortic rings showed the following rank order of potency (Ki, nM): xanthine amino congener (17 +/- 4) > 8-cyclopentyl-1,3-dipropylxanthine (171 +/- 36) > PD 115,199 (341 +/- 64) > 3,7-dimethyl-1-propargylxanthine (5520 +/- 820). 7. We conclude that the A2 adenosine receptor mediating relaxation of phenylephrine-contracted aortic rings is an A2b adenosine receptor which exhibits certain minor differences from the A2b receptor which stimulates cyclic AMP accumulation in cerebral cortical slices.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012695      PMCID: PMC1910056          DOI: 10.1111/j.1476-5381.1994.tb14042.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  RDC8 codes for an adenosine A2 receptor with physiological constitutive activity.

Authors:  C Maenhaut; J Van Sande; F Libert; M Abramowicz; M Parmentier; J J Vanderhaegen; J E Dumont; G Vassart; S Schiffmann
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

2.  Molecular cloning and expression of the cDNA for a novel A2-adenosine receptor subtype.

Authors:  J H Stehle; S A Rivkees; J J Lee; D R Weaver; J D Deeds; S M Reppert
Journal:  Mol Endocrinol       Date:  1992-03

3.  Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord.

Authors:  S M Reppert; D R Weaver; J H Stehle; S A Rivkees
Journal:  Mol Endocrinol       Date:  1991-08

4.  N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptor.

Authors:  A J Bridges; R F Bruns; D F Ortwine; S R Priebe; D L Szotek; B K Trivedi
Journal:  J Med Chem       Date:  1988-07       Impact factor: 7.446

5.  [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.

Authors:  M F Jarvis; R Schulz; A J Hutchison; U H Do; M A Sills; M Williams
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

6.  Cloning and functional characterization of a human A1 adenosine receptor.

Authors:  F Libert; J Van Sande; A Lefort; A Czernilofsky; J E Dumont; G Vassart; H A Ensinger; K D Mendla
Journal:  Biochem Biophys Res Commun       Date:  1992-09-16       Impact factor: 3.575

7.  Molecular cloning and expression of an adenosine A2b receptor from human brain.

Authors:  K D Pierce; T J Furlong; L A Selbie; J Shine
Journal:  Biochem Biophys Res Commun       Date:  1992-08-31       Impact factor: 3.575

8.  Cloning and expression of an A1 adenosine receptor from rat brain.

Authors:  L C Mahan; L D McVittie; E M Smyk-Randall; H Nakata; F J Monsma; C R Gerfen; D R Sibley
Journal:  Mol Pharmacol       Date:  1991-07       Impact factor: 4.436

Review 9.  Adenosine A1 and A2 receptors: structure--function relationships.

Authors:  P J van Galen; G L Stiles; G Michaels; K A Jacobson
Journal:  Med Res Rev       Date:  1992-09       Impact factor: 12.944

10.  The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor.

Authors:  F Libert; S N Schiffmann; A Lefort; M Parmentier; C Gérard; J E Dumont; J J Vanderhaeghen; G Vassart
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

View more
  8 in total

1.  Characterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cells.

Authors:  S P Alexander; J Cooper; J Shine; S J Hill
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  The effects of purine compounds on the isolated aorta of the frog Rana temporaria.

Authors:  G E Knight; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Adenosine receptor-mediated relaxation of guinea-pig precontracted, isolated trachea.

Authors:  A Losinski; S P Alexander
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

4.  Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.

Authors:  J A Cooper; S J Hill; S P Alexander; P C Rubin; E H Horn
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

5.  A2B adenosine receptors mediate relaxation of the pig intravesical ureter: adenosine modulation of non adrenergic non cholinergic excitatory neurotransmission.

Authors:  M Hernández; M V Barahona; S Bustamante; A García-Sacristán; L M Orensanz
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Adenosine induces cyclic-AMP formation and inhibits endothelin-1 production/secretion in guinea-pig tracheal epithelial cells through A(2B) adenosine receptors.

Authors:  S Pelletier; J Dubé; A Villeneuve; F Gobeil; S G Bernier; B Battistini; G Guillemette; P Sirois
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

7.  Effects of pH on responses to adenosine, CGS 21680, carbachol and nitroprusside in the isolated perfused superior mesenteric arterial bed of the rat.

Authors:  C R Hiley; F E Bottrill; J Warnock; P J Richardson
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

8.  A1 adenosine receptor inhibition of cyclic AMP formation and radioligand binding in the guinea-pig cerebral cortex.

Authors:  S P Alexander; A R Curtis; D A Kendall; S J Hill
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.